Impact of Delay in Adjuvant Therapy for Gallbladder Adenocarcinoma

ConclusionCurrent guidelines support the use of adjuvant therapy following resection of GBAC. This national cohort study demonstrates that delays in adjuvant therapy>12  weeks did not impact long-term survival.

Source: Journal of Hepato-Biliary-Pancreatic Sciences - June 4, 2022 Category: Gastroenterology Authors: Ahmad Hamad, Chris Aquina, Aliya Ansari, Aneesa Salahuddin, Chengli Shen, Jordan M. Cloyd, Timothy M. Pawlik, Aslam Ejaz Tags: ORIGINAL ARTICLE Source Type: research